Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (181-190 of 315) with videos related to

Pageof 32
Sort By:
Blood|September 18, 2007
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiencesMohamed L Sorror, Sergio Giralt, Brenda M Sandmaier, et al.
Transplantation|May 13, 2015
Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell TransplantationSteven Lawrence Rosinski, Brad Stone, Scott S Graves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2005
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemiaDaniella M B Kerbauy, Faith Chyou, Ted Gooley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 31, 2009
Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imagingZejing Wang, Rainer Storb, Donghoon Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantationRon Ram, Barry Storer, Marco Mielcarek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigensScott S Tykodi, Edus H Warren, John A Thompson, et al.
Transplantation|May 23, 2002
Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimerasChristian S Kuhr, Margaret D Allen, Christian Junghanss, et al.
Transplantation|November 16, 2011
Tolerance to vascularized composite allografts in canine mixed hematopoietic chimerasDavid W Mathes, Billanna Hwang, Scott S Graves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2025
Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell TransplantationMasumi Ueda Oshima, Phuong T Vo, Michael Boeckh, et al.
Leukemia|April 20, 2022
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationLucas C Zarling, Megan Othus, Brenda M Sandmaier, et al.
Pageof 32

Showing results (181-190 of 315) with videos related to

Sort By:
Pageof 32
Blood|September 18, 2007
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiencesMohamed L Sorror, Sergio Giralt, Brenda M Sandmaier, et al.
Transplantation|May 13, 2015
Development of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell TransplantationSteven Lawrence Rosinski, Brad Stone, Scott S Graves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2005
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemiaDaniella M B Kerbauy, Faith Chyou, Ted Gooley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 31, 2009
Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imagingZejing Wang, Rainer Storb, Donghoon Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantationRon Ram, Barry Storer, Marco Mielcarek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigensScott S Tykodi, Edus H Warren, John A Thompson, et al.
Transplantation|May 23, 2002
Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimerasChristian S Kuhr, Margaret D Allen, Christian Junghanss, et al.
Transplantation|November 16, 2011
Tolerance to vascularized composite allografts in canine mixed hematopoietic chimerasDavid W Mathes, Billanna Hwang, Scott S Graves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2025
Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell TransplantationMasumi Ueda Oshima, Phuong T Vo, Michael Boeckh, et al.
Leukemia|April 20, 2022
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationLucas C Zarling, Megan Othus, Brenda M Sandmaier, et al.
Pageof 32